# Colon-delivered Riboflavin and Gut Microbiota Composition

> **NCT07093463** · NA · RECRUITING · sponsor: **dsm-firmenich Switzerland AG** · enrollment: 90 (estimated)

## Conditions studied

- Microbiome Dysbiosis
- Gut Health

## Interventions

- **DIETARY_SUPPLEMENT:** Colon-delivered riboflavin
- **DIETARY_SUPPLEMENT:** Conventional riboflavin
- **OTHER:** Microcrystalline Cellulose

## Key facts

- **NCT ID:** NCT07093463
- **Lead sponsor:** dsm-firmenich Switzerland AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-18
- **Primary completion:** 2026-08
- **Final completion:** 2026-09
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07093463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07093463, "Colon-delivered Riboflavin and Gut Microbiota Composition". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07093463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*